Liver MRI is not accurate enough to definitely identify patients with iron overload.
Magnetic resonance imaging of the liver may help rule out iron overload, but is not accurate enough to definitely identify patients with the condition, according to an article published in the journal Clinical Gastroenterology and Hepatology.
Researchers from Greece sought to determine if using MRI could help identify patients with iron overload and to guide titration of chelation therapy. Their systematic review and meta-analysis was based on patients with hereditary hemochromatosis, hemoglobinopathy and myelodysplastic syndrome.
A total of 20 studies with 819 patients were chosen for the final analysis. The researchers found that sensitivity and specificity values varied greatly, ranging from 0.00 to 1.00 and from 0.50 to 1.00, respectively.
“Due to substantial heterogeneity and variable positivity thresholds, we calculated only summary receiver operating curves (and summary estimate points for studies that used the same MRI sequences). T2 spin echo and T2* gradient-recalled echo MRI sequences accurately identified patients without liver iron overload (liver iron concentration > 7 mg Fe/g dry liver weight) (negative likelihood ratios, 0.10 and 0.05 respectively),” the authors wrote. “However, these MRI sequences are less accurate in establishing a definite diagnosis of liver iron overload (positive likelihood ratio of 8.85 and 4.86 respectively).”
The authors concluded that while the MRI measurements of iron concentration in the liver may be accurate enough to rule out iron overload, the measurements were not accurate enough to definitely identify patients who may be overloaded.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals
January 6th 2025For hepatocellular carcinoma screening, a 19-study meta-analysis found the abbreviated MRI sequencing protocol of T2-weighted MRI, diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging offered 88 percent sensitivity and 93 percent specificity.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.